CW
DTIL icon

CreativeOne Wealth’s Precision BioSciences DTIL Stock Holding History

CreativeOne Wealth’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-383
Closed -$144K – 702
2021
Q2 		$144K Hold
383
– – 0.01% 657
2021
Q1 		$119K Buy
+383
New +$134K 0.01% 550

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

CreativeOne Wealth's DTIL Position: Q3 2021 in Review

CreativeOne Wealth sold out of Precision BioSciences (DTIL) in Q3 2021, closing a stake of 383 shares — an estimated $144K sold.

CreativeOne Wealth first reported a position in DTIL in Q1 2021 and held it in 2 quarters. The position peaked at $144K in Q2 2021. 132 funds tracked by Wall St. Rank hold DTIL as of Q3 2021.

  • CreativeOne Wealth reported no remaining Precision BioSciences position as of Q3 2021 after selling out during the quarter.
  • CreativeOne Wealth sold 383 Precision BioSciences shares in Q3 2021, an estimated $144K.
  • CreativeOne Wealth first reported a position in Precision BioSciences in Q1 2021 and held it in 2 quarters.
  • CreativeOne Wealth's Precision BioSciences position peaked at $144K in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2021.

Based on CreativeOne Wealth's 13F filing for Q3 2021, filed 16 Nov 2021.